Z-BeEAM (Ibritumomab tiuxetan, Bendamustine, Etoposide, Cytarabine, Melphalan) before autologous stem cell transplantation is safe and efficient for refractory large B-cell lymphoma

BACKGROUND: Refractory or relapsed large B-cells lymphoma are usually treated with a high dose chemotherapy regimen followed by an autolougous stem cells transplantation. BEAM (carmustine, etoposide, cytarabine, melphalan) or more recently Z-BEAM (ibritumomab tiuxetan and BEAM) are commonly used reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Tardy, Magalie P., Gastaud, Lauris, Ojeda-Uribe, Mario, Boscagli, Annick, Caruso, Salvatore, Skaf, Richard, Gutnecht, Jean, Thyss, Antoine, Peyrade, Frédéric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504161/
https://www.ncbi.nlm.nih.gov/pubmed/26185733
http://dx.doi.org/10.1186/s40164-015-0013-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504161/
https://www.ncbi.nlm.nih.gov/pubmed/26185733
http://dx.doi.org/10.1186/s40164-015-0013-2

Ejemplares similares